FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine, and concerns an ophthalmic composition for treating dry eye, which is presented in the form of a water-based liquid solution with its base containing rebamipide, meglumine and boric acid, and/or phosphoric acid, wherein the amount of the inorganic cation, different from hydronium ion in the ophthalmic composition is less than 15 mEq.
EFFECT: invention provides maintaining the transparency of the rebamipide-containing solution.
5 cl, 58 ex, 4 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| NOVEL OPHTHALMIC COMPOSITION CONTAINING REBAMIPIDE, AND METHOD FOR PRODUCTION THEREOF | 2016 |
|
RU2706353C1 |
| AQUEOUS OPHTHALMIC SUSPENSION OF CRYSTAL REBAMIPIDE | 2005 |
|
RU2398585C2 |
| OPHTHALMIC COMPOSITION WITH HIGH CONCENTRATION OF OLOPATADINE | 2012 |
|
RU2613715C2 |
| STABLE AQUEOUS SOLUTION | 2014 |
|
RU2665639C2 |
| BLEACHING AGENT AND COMPOSITION FOR SKIN FOR EXTERNAL APPLICATION | 2009 |
|
RU2434634C1 |
| DIFLUPREDNATE EMULSION COMPOSITION CONTAINING ZINC | 2014 |
|
RU2675813C2 |
| SUSPENSIONS OF NANOPARTICLES, CONTAINING CARBOXYVINYL POLYMER | 2010 |
|
RU2571078C2 |
| AQUEOUS SUSPENSION CONTAINING GLUCOCORTICOSTEROID NANOPARTICLES | 2016 |
|
RU2747803C2 |
| AXELASTIN AND STEROIDS COMBINATION | 2003 |
|
RU2361593C2 |
| PHARMACOLOGICAL COMPOSITION WITH SWELLING COATING | 2004 |
|
RU2375048C2 |
